Evidence map›Paper›PMID 30371151›Full record

Observational studyJournal of the American Heart Association2018

Intake of Vitamin K Antagonists and Worsening of Cardiac and Vascular Disease: Results From the Population-Based Gutenberg Health Study.

Lisa Eggebrecht, Jürgen H Prochaska, Andreas Schulz, Natalie Arnold, Claus Jünger, Sebastian Göbel, Dagmar Laubert-Reh, Harald Binder, Manfred E Beutel, Nobert Pfeiffer and 6 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Journal of the American Heart Association, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Lisa Eggebrecht1 Preventive Cardiology and Preventive Medicine Center for Cardiology University Medical Center Mainz Mainz Germany.
Jürgen H Prochaska1 Preventive Cardiology and Preventive Medicine Center for Cardiology University Medical Center Mainz Mainz Germany.
Andreas Schulz1 Preventive Cardiology and Preventive Medicine Center for Cardiology University Medical Center Mainz Mainz Germany.
Natalie Arnold1 Preventive Cardiology and Preventive Medicine Center for Cardiology University Medical Center Mainz Mainz Germany.
Claus Jünger1 Preventive Cardiology and Preventive Medicine Center for Cardiology University Medical Center Mainz Mainz Germany.
Sebastian Göbel2 Center for Translational Vascular Biology (CTVB) University Medical Center Mainz Mainz Germany.
Dagmar Laubert-Reh1 Preventive Cardiology and Preventive Medicine Center for Cardiology University Medical Center Mainz Mainz Germany.
Harald Binder2 Center for Translational Vascular Biology (CTVB) University Medical Center Mainz Mainz Germany.
Manfred E Beutel2 Center for Translational Vascular Biology (CTVB) University Medical Center Mainz Mainz Germany.
Nobert Pfeiffer2 Center for Translational Vascular Biology (CTVB) University Medical Center Mainz Mainz Germany.
Stefan Blankenberg9 Clinic for General and Interventional Cardiology University Heart Centre Hamburg Hamburg Germany.
Karl J Lackner2 Center for Translational Vascular Biology (CTVB) University Medical Center Mainz Mainz Germany.
Henri M Spronk12 Laboratory for Clinical Thrombosis and Hemostasis Department of Internal Medicine Cardiovascular Research Institute Maastricht (CARIM) Maastricht University Medical Center Maastricht The Netherlands.
Hugo Ten Cate3 Center for Thrombosis and Hemostasis University Medical Center Mainz Mainz Germany.
Thomas Münzel2 Center for Translational Vascular Biology (CTVB) University Medical Center Mainz Mainz Germany.
Philipp S Wild1 Preventive Cardiology and Preventive Medicine Center for Cardiology University Medical Center Mainz Mainz Germany.
Johannes Gutenberg University Mainz · DEUniversity Medical Center of the Johannes Gutenberg University Mainz · DEGerman Centre for Cardiovascular Research · DEMaastricht University · NLUniversity of Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Preclinical data have indicated a link between use of vitamin K antagonists ( VKA ) and detrimental effects on vascular structure and function. The objective of the present study was to determine the relationship between VKA intake and different phenotypes of subclinical cardiovascular disease in the population. Methods and Results Clinical and laboratory data, as well as medical-technical examinations were assessed from 15 010 individuals aged 35 to 74 years during a highly standardized 5-hour visit at the study center of the population-based Gutenberg Health Study. In total, the study sample comprised 287 VKA users and 14 564 VKA nonusers. Multivariable analysis revealed an independent association between VKA intake and stiffness index (β=+2.54 m/s; [0.41/4.66]; P=0.019), ankle-brachial index (β=-0.03; [-0.04/-0.01]; P<0.0001), intima-media thickness (β=+0.03 mm [0.01/0.05]; P=0.0098), left ventricular ejection fraction (β=-4.02% [-4.70/-3.33]; P<0.0001), E/E' (β=+0.04 [0.01/0.08]; P=0.014) left ventricular mass (β=+5.34 g/m

Indexed as

Stroke VolumeVascular StiffnessAdrenomedullinAdultAgedAnkle Brachial IndexAnticoagulantsAsymptomatic DiseasesAtrial FibrillationAtrial Natriuretic FactorCardiovascular DiseasesCarotid Intima-Media ThicknessC-Reactive ProteinFemaleFibrinogenGermanyAdrenomedullinAnticoagulantsAtrial Natriuretic FactorC-Reactive ProteinFibrinogenmid-regional pro-adrenomedullin, humanmidregional pro-atrial natriuretic peptide, humanNatriuretic Peptide, BrainPeptide FragmentsPhenprocoumonpro-brain natriuretic peptide (1-76)Protein PrecursorsWarfarincardiovascular diseaseoral anticoagulationpharmacogenomic variantsvitamin K antagonists

Identifiers

PMID30371151
PMCPMC6201416
OpenAlexW2889462133

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.